These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12195264)

  • 1. Complications and adverse reactions with the use of botulinum toxin.
    Klein AW
    Dis Mon; 2002 May; 48(5):336-56. PubMed ID: 12195264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications and adverse reactions with the use of botulinum toxin.
    Klein AW
    Semin Cutan Med Surg; 2001 Jun; 20(2):109-20. PubMed ID: 11474743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications with the use of botulinum toxin.
    Klein AW
    Dermatol Clin; 2004 Apr; 22(2):197-205, vii. PubMed ID: 15222580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and management of locoregional complications of botulinum A toxin injections in cosmetic treatment].
    Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S146-51. PubMed ID: 19576482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double vision due to lateral rectus injury after cosmetic botulinum toxin injections.
    Khan S; Pathak G; Milgraum D; Tamhankar M; Milgraum S
    Australas J Dermatol; 2023 Aug; 64(3):e220-e223. PubMed ID: 37386928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation.
    Aristodemou P; Watt L; Baldwin C; Hugkulstone C
    Ophthalmic Plast Reconstr Surg; 2006; 22(2):134-6. PubMed ID: 16550061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A (BOTOX) for treatment of migraine.
    Binder WJ; Brin MF; Blitzer A; Pogoda JM
    Dis Mon; 2002 May; 48(5):323-35. PubMed ID: 12195263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: "Botulinum toxin type A as a migraine preventive treatment" (Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445-450).
    Galvez-Jimenez N; Hanson MR
    Headache; 2001 Jun; 41(6):607. PubMed ID: 11437903
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies.
    Cavallini M; Cirillo P; Fundarò SP; Quartucci S; Sciuto C; Sito G; Tonini D; Trocchi G; Signorini M
    Dermatol Surg; 2014 May; 40(5):525-36. PubMed ID: 24575858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures.
    Wollina U; Konrad H
    Am J Clin Dermatol; 2005; 6(3):141-50. PubMed ID: 15943491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of wrinkles with Botox.
    Klein AW
    Curr Probl Dermatol; 2002; 30():188-217. PubMed ID: 12471713
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
    Sheen-Ophir S; Almog Y
    Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigation of risk of botulinum toxin A-induced blepharoptosis with hyperconcentrated glabellar injections.
    Ghanian S; Wambier SPF; Wambier CG
    J Am Acad Dermatol; 2024 Jun; 90(6):1309-1310. PubMed ID: 38151057
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution.
    Labadie JG; Dover JS
    J Am Acad Dermatol; 2024 Jun; 90(6):1311-1312. PubMed ID: 38151056
    [No Abstract]   [Full Text] [Related]  

  • 17. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation.
    Dolar Bilge A; Sadigov F; Salar-Gomceli S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports.
    Isaac CR; Chalita MR; Pinto LD
    Arq Bras Oftalmol; 2012; 75(3):213-4. PubMed ID: 22872208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diplopia following subcutaneous injections of botulinum A toxin for facial spasms.
    Wutthiphan S; Kowal L; O'Day J; Jones S; Price J
    J Pediatr Ophthalmol Strabismus; 1997; 34(4):229-34. PubMed ID: 9253737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of botulinum A exotoxin for hyperfunctional lines.
    Matarasso SL
    Dermatol Surg; 1998 Nov; 24(11):1249-54. PubMed ID: 9834747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.